E
Emilio Iannitto
Researcher at University of Palermo
Publications - 101
Citations - 5361
Emilio Iannitto is an academic researcher from University of Palermo. The author has contributed to research in topics: Splenic marginal zone lymphoma & Lymphoma. The author has an hindex of 31, co-authored 99 publications receiving 4963 citations.
Papers
More filters
Journal ArticleDOI
Early Interim 2-[18F]Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography Is Prognostically Superior to International Prognostic Score in Advanced-Stage Hodgkin's Lymphoma: A Report From a Joint Italian-Danish Study
Andrea Gallamini,Martin Hutchings,Luigi Rigacci,Lena Specht,Francesco Merli,Mads Hansen,Caterina Patti,Annika Loft,Francesco Di Raimondo,Francesco d'Amore,Alberto Biggi,Umberto Vitolo,Caterina Stelitano,R Sancetta,Livio Trentin,Stefano Luminari,Emilio Iannitto,Simonetta Viviani,Ivana Pierri,Alessandro Levis +19 more
TL;DR: PET-2 overshadows the prognostic value of IPS and emerges as the single most important tool for planning of risk-adapted treatment in advanced HL.
Journal ArticleDOI
Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical study
Andrea Gallamini,Caterina Stelitano,R Calvi,Monica Bellei,Daniele Mattei,Umberto Vitolo,Fortunato Morabito,Maurizio Martelli,Ercole Brusamolino,Emilio Iannitto,Francesco Zaja,Sergio Cortelazzo,Luigi Rigacci,Liliana Devizzi,Giuseppe Todeschini,Gino Santini,Maura Brugiatelli,Massimo Federico +17 more
TL;DR: To assess the prognosis of peripheral T-cell lymphoma unspecified, retrospectively analyzed 385 cases fulfilling the criteria defined by the World Health Organization classification and constructed a new prognostic model that singled out 4 groups at different risk.
Journal ArticleDOI
Hepatitis C virus and B-cell non-Hodgkin lymphomas: an Italian multicenter case-control study
Alfonso Mele,Alessandro Pulsoni,Elvira Bianco,Pellegrino Musto,Andrè Szklo,Maria Grazia Sanpaolo,Emilio Iannitto,Amalia De Renzo,Bruno Martino,Vincenzo Liso,Cristina Andrizzi,Simona Pusterla,Fausto Dore,Maddalena Maresca,Maria Rapicetta,Fabrizio Marcucci,Franco Mandelli,Silvia Franceschi +17 more
TL;DR: This study confirms an association between HCV and B-NHL and in Italy, 1 of 20 instances of B-nHL may be attributable to HCV infection and may, thus, benefit from antiviral treatment.
Journal ArticleDOI
Alemtuzumab (Campath-1H) and CHOP chemotherapy as first-line treatment of peripheral T-cell lymphoma: results of a GITIL (Gruppo Italiano Terapie Innovative nei Linfomi) prospective multicenter trial
Andrea Gallamini,Francesco Zaja,Caterina Patti,Atto Billio,Maria Rosaria Specchia,Alessandra Tucci,Alessandro Levis,Annunziata Manna,Vincenzo Secondo,Luigi Rigacci,Antonello Pinto,Emilio Iannitto,Valerio Zoli,Pierfederico Torchio,Stefano Pileri,Corrado Tarella +15 more
TL;DR: CHOP-C is a feasible chemoimmunotherapy regimen; it is effective in PTCL with a high rate of CR achievement; and it is associated with mostly manageable infectious complications.
Journal ArticleDOI
The predictive value of positron emission tomography scanning performed after two courses of standard therapy on treatment outcome in advanced stage Hodgkin's disease
Andrea Gallamini,Luigi Rigacci,Francesco Merli,Luca Nassi,Alberto Bosi,Isabella Capodanno,Stefano Luminari,Umberto Vitolo,Rosaria Sancetta,Emilio Iannitto,Livio Trentin,Caterina Stelitano,Silvia Tavera,Alberto Biggi,Antonio Castagnoli,Annibale Versari,Michele Gregianin,Ettore Pelosi,Pierfederico Torchio,Alessandro Levis +19 more
TL;DR: 18F-FDG-PET scan performed after two courses of conventional standard-dose chemotherapy in advanced-stage Hodgkin's disease was able to predict treatment outcome in 103/108 (95%) of the patients, and the positive predictive value of a PET-2 was 90% and the negative predictive value was 97%.